Table 1 Clinical and demographic characteristics of the 122 infants
From: Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023
Clinical and demographic characteristics | Number of drugs/type | Z/χ2 | P | r | P | |||
|---|---|---|---|---|---|---|---|---|
Gender | Male | 66 | 54.09% | 1757 (60%) | -0.121 | 0.904 | 0.01 | 0.911 |
Female | 56 | 45.90% | 1169 (40%) | |||||
Mode of delivery* | Natural birth | 44 | 36.66% | 1058 (36.2%) | -0.398 | 0.690 | -0.036 | 0.692 |
Cesarean section | 76 | 62.30% | 1868 (63.8%) | |||||
Gestational age/week* | 24–30 | 10 | 8.33% | 349 (11.92%) | 11.270 | 0.01 | -0.375 | 0.000 |
31–33 | 6 | 5.0% | 386 (13.19%) | |||||
34–36 | 26 | 21.66% | 718 (24.54%) | |||||
> 37 | 78 | 65.0% | 1473 (50.34% ) | |||||
Birth weight/g* | 1000–1499 | 11 | 9.16% | 380 (12.98%) | 9.213 | 0.01 | -0.365 | 0.000 |
1500–2499 | 27 | 22.50% | 769 (26.28) | |||||
> 2500 | 82 | 68.33% | 1777 (60.73%) | |||||
Length of stay/d | 1–7 | 55 | 45.08% | 673 (23%) | 41.669 | 0.000 | 0.625 | 0.000 |
8–14 | 28 | 22.95% | 677 (23.13%) | |||||
15–21 | 12 | 9.83% | 349 (11.92%) | |||||
> 21 | 27 | 22.13% | 1227 (41.93%) | |||||
Apgar score/points | 1 min | -0.325 | 0.000 | |||||
5 min | -0.346 | 0.000 | ||||||
10 min | -0.334 | 0.000 | ||||||
Clinical outcomes | Normal | 68 | 55.73% | 1634 (55.84%) | ||||
Improvement | 50 | 40.98% | 1195 (40.84%) | 8.615 | 0.013 | -0.268 | 0.003 | |
Death | 4 | 3.28% | 97 (3.31%) | |||||